Sunways Bioscience Export Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 81.34%
(FY 2023)
- Profit 19.12%
(FY 2023)
- Ebitda 9.21%
(FY 2023)
- Net Worth 59.03%
(FY 2023)
- Total Assets 15.53%
(FY 2023)
About Sunways Bioscience Export
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Sharma and Thangasamy Arumugam serve as directors at the Company.
- CIN/LLPIN
U24240MH2019PTC323786
- Company No.
323786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sunways Bioscience Export?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Sharma  | Director | 08-Apr-2019 | Current |
| Thangasamy Arumugam | Director | 08-Apr-2019 | Current |
Financial Performance of Sunways Bioscience Export.
Sunways Bioscience Export Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 81.34% increase. The company also saw a substantial improvement in profitability, with a 19.12% increase in profit. The company's net worth Soared by an impressive increase of 59.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunways Bioscience Export?
In 2023, Sunways Bioscience Export had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunways Bio-Science LlpActive 7 years 2 monthsNeeraj Sharma and Thangasamy Arumugam are mutual person
- Mantra Shipping And Logistics Private LimitedActive 5 years 5 months
Neeraj Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sunways Bioscience Export?
Sunways Bioscience Export has a workforce of 4 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunways Bioscience Export, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunways Bioscience Export's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
